

HY-171331 · 50 mg
MedChemExpress · Cat: HY-171331
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ab-3prgd2.html
Description
AB-3PRGD2 is a radiotherapeutic agent targeting integrin ?v?3. AB-3PRGD2 shows improved tumor uptake and prolonged tumor retention, leading to significantly enhanced tumor growth suppression. AB-3PRGD2 can remodel the tumor immune microenvironment by upregulating PD-L1 expression and increasing tumor-infiltrating CD8+ T cells.







